NRC HEALTH
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M |
| Operating income | $22.6M | $35.2M | $40.0M | $46.5M | $50.3M |
| Cash from operations | $26.4M | $34.6M | $38.1M | $36.3M | $46.3M |
| Capital expenditure | $10.7M | $15.4M | $15.8M | $9.8M | $5.5M |
| Free cash flow | $15.7M | $19.2M | $22.3M | $26.4M | $40.8M |
| Share repurchases | $20.2M | $30.9M | $19.1M | $27.6M | $4.1M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $134.9M | $132.5M | $122.4M | $130.5M | $157.5M |
| Total liabilities | $120.9M | $101.3M | $73.5M | $58.4M | $72.2M |
Shares outstanding 22.5M · Free float 12.2%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.